Print

ARVO's Bench to Bedside (B2B) Meeting

Bench to Bedside Meeting Beginning in 2020, ARVO will launch a unique program to educate members on how to advance translational ideas to clinically applied products. This program will encourage and foster an innovation mindset amongst ARVO members.

The new B2B program, which will be geared toward the pipeline's early stage, will provide companies with an opportunity to share the trials and tribulations of taking a new discovery to the market with researchers from across the globe. The event will include opportunities for interaction between innovators and venture capitalists, including education on how to obtain funding and enter the beginning and middle phases of clinical trials. Additionally, the program will offer guidance on technology transfer, patents and regulatory concerns.

The first B2B Meeting will take place on Friday, May 1, 2020, in conjunction with the ARVO Annual Meeting in Baltimore, Maryland.

The program will include a mix of accepted and invited presentations, "shark-tank"-style pitches to venture capitalists and other interactive and networking formats. A preliminary program format has been identified and more details are to follow.